Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2025 Earnings Call Transcript
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2025 Earnings Call Transcript August 12, 2025Spero Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.38.





